An interesting evaluation winged its way into Editorial over the Christmas break, and got waved under my nose ahead of publication. According to a paper published in J Clin Psychopharmacol last August, a double-blind placebo-controlled trial of oral chamomile extract showed a modest anxiolytic activity in patients with mild to moderate generalized anxiety disorder. Despite…